Alexithymia, suicidal ideation, and serum lipid levels among drug-naïve outpatients with obsessive-compulsive disorder

Revista Brasileira de Psiquiatria

Volumn 36, Issue 2, 2014, Pages 125-130

  De Berardis, Domenico ^a,b   Serroni, Nicola ^a   Marini, Stefano ^a   Rapini, Gabriella ^a   Carano, Alessandro ^b   Valchera, Alessandro ^c   Iasevoli, Felice ^d   Mazza, Monica ^e   Signorelli, Maria ^f   Aguglia, Eugenio ^f   Perna, Giampaolo ^g,h,i   Martinotti, Giovanni ^c   Varasano, Paola A ^a   Pressanti, Gabriella Lucidi ^a   Di Giannantonio, Massimo ^b  

^a G Mazzini Hospital   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c Casa di Cura San Giuseppe   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF L'AQUILA   (Italy)

^f UNIVERSITY OF CATANIA   (Italy)

^g MAASTRICHT UNIVERSITY   (Netherlands)

^h Department of Clinical Neurosciences Villa San Benedetto Menni ^*  (Italy)

ⁱ UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Alexithymia; Drug na ve; Obsessive compulsive disorder; Serum lipid levels; Suicide ideation

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALEXITHYMIA; ARTICLE; CLINICAL ASSESSMENT; COMPULSION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; HUMAN; INTRARATER RELIABILITY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OBSESSION; OBSESSIVE COMPULSIVE DISORDER; RATING SCALE; SCORING SYSTEM; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SUICIDAL IDEATION; TORONTO ALEXITHYMIA SCALE; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

ADOLESCENT; ADULT; AFFECTIVE SYMPTOMS; ANALYSIS OF VARIANCE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; OUTPATIENTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REFERENCE VALUES; RISK FACTORS; SUICIDAL IDEATION; YOUNG ADULT;

EID: 84901236933     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/1516-4446-2013-1189     Document Type: Article

References (42)

1. De Berardis D, Campanella D, Serroni N, Sepede G, Carano A, Conti C, et al. The impact of alexithymia on anxiety disorders: a review of the literature. Curr Psychiatry Rev. 2008;4:80-6.
2. De Berardis D, Campanella D, Gambi F, Sepede G, Salini G, Carano A, et al. Insight and alexithymia in adult outpatients with obsessivecompulsive disorder. Eur Arch Psychiatry Clin Neurosci. 2005;255:350-8.
3. De Berardis D, Conti CM, Serroni N, Moschetta FS, Carano A, Salerno RM, et al. The role of cholesterol levels in mood disorders and suicide. J Biol Regul Homeost Agents. 2009;23:133-40.
4. Balci V, Sevincok L. Suicidal ideation in patients with obsessivecompulsive disorder. Psychiatry Res. 2010;175:104-8.
5. De Berardis D, Serroni N, Campanella D, Carano A, Caltabiano M, Pizzorno AM, et al. Rischio suicidario in pazienti con disturbo ossessivo-compulsivo: il ruolo dell'alessitimia e dell'insight. Giorn Ital Psicopat. 2008;14:185-96.
6. Hintikka J, Honkalampi K, Koivumaa-Honkanen H, Antikainen R, Tanskanen A, Haatainen K, et al. Alexithymia and suicidal ideation: a 12-month follow-up study in a general population. Compr Psychiatry. 2004;45:340-5.
7. Pompili M. Exploring the phenomenology of suicide. Suicide Life Threat Behav. 2010;40:234-44.
8. De Berardis D, Campanella D, Serroni N, Moschetta FS, Di Emidio F, Conti C, et al. Alexithymia, suicide risk and serum lipid levels among adult outpatients with panic disorder. Compr Psychiatry. 2013; 54:517-22.
9. Papakostas GI, Ongür D, Iosifescu DV, Mischoulon D, Fava M. Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses. Eur Neuropsychopharmacol. 2004;14:135-42.
10. De Berardis D, Serroni N, Campanella D, Carano A, Gambi F, Valchera A, et al. Alexithymia and its relationships with C-reactive protein and serum lipid levels among drug nai{dotless}ve adult outpatients with major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1982-6.
11. Peter H, Hand I, Hohagen F, Koenig A, Mindermann O, Oeder F, et al. Serum cholesterol level comparison: control subjects, anxiety disorder patients, and obsessive-compulsive disorder patients. Can J Psychiatry. 2002;47:557-61.
12. Agargun MY, Dulger H, Inci R, Kara H, Ozer OA, Sekeroglu MR, et al. Serum lipid concentrations in obsessive-compulsive disorder patients with and without panic attacks. Can J Psychiatry. 2004; 49:776-8.
13. Fiedorowicz JG, Palagummi NM, Behrendtsen O, Coryell WH. Cholesterol and affective morbidity. Psychiatry Res. 2010;175:78-81.
14. Papadopoulou A, Markianos M, Christodoulou C, Lykouras L. Plasma total cholesterol in psychiatric patients after a suicide attempt and in follow-up. J Affect Disord. 2013;148:440-3.
15. Perez-Rodriguez MM, Baca-Garcia E, Diaz-Sastre C, Garcia-Resa E, Ceverino A, Saiz-Ruiz J, et al. Low serum cholesterol may be associated with suicide attempt history. J Clin Psychiatry. 2008;69:1920-7.
16. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989; 46:1006-11.
17. Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry. 1999;156:1409-16.
18. Bressi C, Taylor G, Parker J, Bressi S, Brambilla V, Aguglia E, et al. Cross validation of the factor structure of the 20-item Toronto Alexithymia Scale: an Italian multicenter study. J Psychosom Res. 1996;41:551-9.
19. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol. 1979;47:343-52.
20. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-9.
21. Freyberger H. Supportive psychotherapeutic techniques in primary and secondary alexithymia. Psychother Psychosom. 1977;28:337-42.
22. Zhang J, McKeown RE, Hussey JR, Thompson SJ, Woods JR, Ainsworth BE. Low HDL cholesterol is associated with suicide attempt among young healthy women: the Third National Health and Nutrition Examination Survey. J Affect Disord. 2005;89:25-33.
23. Iancu I, Dannon PN, Poreh A, Lepkifker E, Grunhaus L. Alexithymia and suicidality in panic disorder. Compr Psychiatry. 2001;42:477-81.
24. Marasco V, De Berardis D, Serroni N, Campanella D, Acciavatti T, Caltabiano M, et al. [Alexithymia and suicide risk among patients with schizophrenia: preliminary findings of a cross-sectional study]. Riv Psichiatr. 2011;46:31-7.
25. Kauhanen J, Kaplan GA, Cohen RD, Julkunen J, Salonen JT. Alexithymia and risk of death in middle-aged men. J Psychosom Res. 1996;41:541-9.
26. Sakuraba S, Kubo M, Komoda T, Yamana J. Suicidal ideation and alexithymia in patients with alcoholism: a pilot study. Subst Use Misuse. 2005;40:823-30.
27. Torres AR, de Abreu Ramos-Cerqueira AT, Torresan RC, de Souza Domingues M, Hercos AC, Guimarães AB. Prevalence and associated factors for suicidal ideation and behaviors in obsessivecompulsive disorder. CNS Spectr. 2007;12:771-8.
28. Apter A, Horesh N, Gothelf D, Zalsman G, Erlich Z, Soreni N, et al. Depression and suicidal behavior in adolescent inpatients with obsessive compulsive disorder. J Affect Disord. 2003;75:181-9.
29. Pfrieger FW. Cholesterol homeostasis and function in neurons of the central nervous system. Cell Mol Life Sci. 2003;60:1158-71.
30. Lalovic A, Levy E, Luheshi G, Canetti L, Grenier E, Sequeira A, et al. Cholesterol content in brains of suicide completers. Int J Neuropsychopharmacol. 2007;10:159-66.
31. Freemantle E, Mechawar N, Turecki G. Cholesterol and phospholipids in frontal cortex and synaptosomes of suicide completers: Relationship with endosomal lipid trafficking genes. J Psychiatr Res. 2013;47:272-9.
32. Vevera J, Fisar Z, Kvasnicka T, Zdenek H, Stárková L, Ceska R, et al. Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission. Psychiatry Res. 2005;133:197-203.
33. Wallner B, Machatschke IH. The evolution of violence inmen: the function of central cholesterol and serotonin. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:391-7.
34. Ruljancic N, Mihanovic M, Cepelak I. Thrombocyte serotonin and serum cholesterol concentration in suicidal and non-suicidal depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:1261-7.
35. Zhang J. Epidemiological link between low cholesterol and suicidality: a puzzle never finished. Nutr Neurosci. 2011;14:268-87.
36. Kuloglu M, Atmaca M, Tezcan E, Gecici O, Tunckol H, Ustundag B. Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder. Neuropsychobiology. 2002; 46:27-32.
37. Behl A, Swami G, Sircar SS, Bhatia MS, Banerjee BD. Relationship of possible stress-related biochemical markers to oxidative/antioxidative status in obsessive-compulsive disorder. Neuropsychobiology 2010;61:210-4.
38. Richter J, Möller B, Spitzer C, Letzel S, Bartols S, Barnow S, et al. Transcallosal inhibition in patients with and without alexithymia. Neuropsychobiology. 2006;53:101-7.
39. Kano M, Fukudo S, Gyoba J, Kamachi M, Tagawa M, Mochizuki H, et al. Specific brain processing of facial expressions in people with alexithymia: an H2 15O-PET study. Brain. 2003;126:1474-84.
40. Berthoz S, Artiges E, Van De Moortele PF, Poline JB, Rouquette S, Consoli SM, et al. Effect of impaired recognition and expression of emotions on frontocingulate cortices: an fMRI study of men with alexithymia. Am J Psychiatry. 2002;159:961-7.
41. Del Casale A, Kotzalidis GD, Rapinesi C, Serata D, Ambrosi E, Simonetti A, et al. Functional neuroimaging in obsessive-compulsive disorder. Neuropsychobiology. 2011;64:61-85.
42. Raust A, Slama F, Mathieu F, Roy I, Chenu A, Koncke D, et al. Prefrontal cortex dysfunction in patients with suicidal behavior. Psychol Med. 2007;37:411-9.